Göm menyn

Publications for Niklas Theorin

Co-author map based on Web of Sciences articles 2007-

Journal Articles

M. Mohty, M. Labopin, R. Tabrizzi, Niklas Theorin, A.A. Fauser, A. Rambaldi, J. Maertens, S. Slavin, I. Majolino, A. Nagler, D. Blaise and V. Rocha
  Reduced intensity conditioning allogeneic stem cell transplantation for adult patients with acute lymphoblastic leukemia: A retrospective study from the European Group for Blood and Marrow Transplantation
  Haematologica, 2008, 93(2), 303-306.
 Web of Science® Times Cited: 72

Norbert-Claude Gorin, Myriam Labopin, Jean-Michel Boiron, Niklas Theorin, Tim Littlewood, Shimon Slavin, Hildegard Greinix, Jean Yves Cahn, E. Paolo Alessandrino, Alessandro Rambaldi, Arnon Nagler, Emmanuelle Polge and Vanderson Rocha
  Results of genoidentical hemopoietic stem cell transplantation with reduced intensity conditioning for acute myelocytic leukemia: Higher doses of stem cells infused benefit patients receiving transplants in second remission or beyond - The acute leukemia
  Journal of Clinical Oncology, 2006, 24(24), 3959-3966.
 Web of Science® Times Cited: 33

Gunnar Juliusson, Niklas Theorin, Karin Karlsson, U Frödin and Claes Malm
  Subcutaneous alemtuzumab vs ATG in adjusted conditioning for allogeneic transplantation: Influence of Campath dose on lymphoid recovery, mixed chimerism and survival
  Bone Marrow Transplantation, 2006, 37(5), 503-510.
 Web of Science® Times Cited: 41

Conference Articles

Mohamad Mohty, Myriam Labopin, Noel-Jean Milpied, Didier Blaise, Eefke Petersen, Niklas Theorin, Hakan Goker and Gerard Socie
  Impact of Cytogenetics Risk on Outcome after Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) from An HLA Identical Sibling for Patients with Acute Myeloid Leukemia (AML) in First Complete Remission (CR1)
  American Society of Hematology Meeting: in: Blood Volume 112, Issue 11, 2008.

 Web of Science® Times Cited: 3


Responsible for this page: Peter Berkesand
Last updated: 2017-02-21